Beryl Capital Management LLC
Q2 2025 13F-HR Holdings
Net value change ($000)
—
New positions
28
Sold out positions
0
Turnover %
100.0%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to previous filing: —
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| BPMC | 136,797 | — |
| SKAA | 135,974 | — |
| SpringWorks Therapeutics, Inc. | 99,505 | — |
| DNB | 66,345 | — |
| Vigil Neuroscience, Inc. | 36,620 | — |
| AVDX | 28,721 | — |
| CTLP | 27,709 | — |
| INOZYME PHARMA INC | 25,286 | — |
| G | 23,426 | — |
| DKS | 13,632 | — |
Top Reduces (Value $000, Stocks/ETFs)
| — |
Instrument mix + QoQ Δ (ex-options)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|